Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
about
Hypercholesterolemia Tunes Hematopoietic Stem/Progenitor Cells for Inflammation and AtherosclerosisHDL in sepsis - risk factor and therapeutic approachEmerging role of mast cells and macrophages in cardiovascular and metabolic diseasesAnti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cellsHigh-Density Lipoproteins: Nature's Multifunctional NanoparticlesImproving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injuryA high throughput biochemical fluorometric method for measuring lipid peroxidation in HDLPathways by which reconstituted high-density lipoprotein mobilizes free cholesterol from whole body and from macrophagesImproved insulin sensitivity in high fat- and high cholesterol-fed Ldlr-/- mice with macrophage-specific transgenic expression of cholesteryl ester hydrolase: role of macrophage inflammation and infiltration into adipose tissue.Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementDiabetic HDL is dysfunctional in stimulating endothelial cell migration and proliferation due to down regulation of SR-BI expressionReconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitusSkeletal muscle insulin resistance associated with cholesterol-induced activation of macrophages is prevented by high density lipoprotein.Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis.Tristetraprolin-dependent post-transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A-I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3.Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization.CETP expression reverses the reconstituted HDL-induced increase in VLDL.Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and functionApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice.Circulating plasma cholesteryl ester transfer protein activity and blood pressure tracking in the community.A biochemical fluorometric method for assessing the oxidative properties of HDL.Future therapeutic directions in reverse cholesterol transport.Novel HDL-directed pharmacotherapeutic strategies.Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester UptakeApoA-1 mimetic restores adiponectin expression and insulin sensitivity independent of changes in body weight in female obese mice.Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity.Bone mineral density and cardiovascular risk factors in postmenopausal women with coronary artery diseaseCholesterol efflux assay.Targeting high density lipoproteins in the prevention of cardiovascular disease?High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphateGlycation of apoprotein A-I is associated with coronary artery plaque progression in type 2 diabetic patients.Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study.High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: Role of STAT3 as part of the SAFE pathway.Why targeting HDL should work as a therapeutic tool, but has not.Untrained young men have dysfunctional HDL compared with strength-trained men irrespective of body weight statusDifferent relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular diseaseHDL as a biomarker, potential therapeutic target, and therapyLipoteichoic acid isolated from Lactobacillus plantarum suppresses LPS-mediated atherosclerotic plaque inflammation.
P2860
Q26742064-00B457EE-CF8A-43BD-814C-97A10DE57542Q26777964-1B8C2271-2516-47C9-99BC-5B1662F23EE1Q26825467-22E97913-5A61-4C35-9502-CEDEA7E185A4Q27012536-0300755F-E204-4061-841F-83F195605816Q28077290-D89D4FFD-6E92-4E73-B75E-C93C1C2A90F7Q28544407-9FE7DF70-BE69-4C56-93F0-DA5F356648B9Q28544713-9B24B5D4-21C6-4E53-8785-4A3AD3674117Q33743839-32C19DE3-7209-4312-B4BF-1AFF3CEC3AA6Q33810018-AB0221E1-3AF9-4DDA-96CF-C96CBD95FE96Q34144449-D8E8FAA5-D638-4422-A947-55B7EA2D6555Q34181381-87115DEB-810D-41EC-82C1-3A454E6AA404Q34469753-970B73A1-C93C-445C-8746-0D51FEECC06BQ34560800-54B45AD1-B60A-477B-99F8-19D5B405158BQ34599077-D8B60A72-E020-4F6E-98F2-99C1229D6838Q34781496-1AB0F72A-CC35-422D-8205-C37BFE682994Q34799841-3F1AFBB8-F220-43C8-B772-67F6AC6BB921Q34992608-D8AA2C70-06EF-40D4-8850-D3B4E85B9FD6Q35107299-57EE6B65-D9A3-40CE-A8DB-64207FAD92F6Q35131581-DA03D8DC-A68B-4AA5-8D0C-81CDDA46F1B9Q35370268-CFCE8832-6A33-436F-AFD8-4E325D7B0B92Q35485969-0F0DB114-A911-4BBE-9DD6-BE79349E994FQ35562004-F16E4D0D-0844-40E9-A374-C8C12647E6E2Q35860010-E1B9D8A1-AEAE-4FAC-8C4A-3381AC8C83A7Q35860020-BB5ED894-F5A0-4EDC-8823-0F4B34AE100CQ35860634-7B6900F3-BE77-4879-848B-594F09CC586BQ35926657-66961054-59C5-44AC-A1D4-FE699E378725Q36130121-B541A0C5-C270-4704-865F-3D663362F4E0Q36277594-6ACF2F92-6385-4E71-99FF-7706F38D7BD1Q36286514-9EBA92CB-C26C-46D7-A68A-8BC583F84F65Q36453173-8E0EFDAB-B812-4619-8E56-6DB9985B7BBFQ36691031-DB298A26-214A-43E2-B22A-633F594B07BFQ36782743-1125EF93-EBD7-4D99-B8FF-1731007C1E02Q36842216-9EA08321-786A-48B6-84F6-72B68B0E3840Q36895483-15F6B8CF-E730-4D93-9778-20DDB0FD94E6Q37170464-85797FCC-24FE-477D-BF02-687A6789DC20Q37235070-66E77164-44A2-4ED6-9F28-A84BB9871122Q37251396-096CBA2E-A737-4B4D-8943-F80F3AD74799Q37305341-F85218FA-0877-4CFB-8A2A-18217CA61A9CQ37429173-231F130B-5EF9-4BB7-9EBF-9B2274BD3A89Q37462325-526A4CAA-7671-4DC2-BCEA-1D6AB75ED9E2
P2860
Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Reconstituted high-density lip ...... patients with type 2 diabetes.
@en
Reconstituted high-density lip ...... patients with type 2 diabetes.
@nl
type
label
Reconstituted high-density lip ...... patients with type 2 diabetes.
@en
Reconstituted high-density lip ...... patients with type 2 diabetes.
@nl
prefLabel
Reconstituted high-density lip ...... patients with type 2 diabetes.
@en
Reconstituted high-density lip ...... patients with type 2 diabetes.
@nl
P2093
P921
P1476
Reconstituted high-density lip ...... patients with type 2 diabetes
@en
P2093
Brian G Drew
Bronwyn A Kingwell
David S Celermajer
Dmitri Sviridov
Jaye Chin-Dusting
Kerry-Anne Rye
Phillip J Barter
Sanjay Patel
Shirley Nakhla
P304
P356
10.1016/J.JACC.2008.12.008
P407
P577
2009-03-01T00:00:00Z